ALLMedicine Peripartum Cardiomyopathy Center

May 24th, 2020 - The European Society of Cardiology Heart Failure Association Study Group on Peripartum Cardiomyopathy - what has been achieved in 10 years.|2020|Sliwa K,Bauersachs J,Coats AJ,|

May 11th, 2020 - Peripartum cardiomyopathy: can the link between prolactin and PAI-1 provide a clue?|2020|Gorog DA,Vilahur G,|

May 4th, 2020 - Normal cardiac contractile and relaxation function are critically dependent on a continuous energy supply. Accordingly, metabolic perturbations and impaired mitochondrial bioenergetics with subsequent disruption of ATP production underpin a wide v...

Apr 27th, 2020 - Peripartum cardiomyopathy, a traumatic life-threatening type of heart failure, occurs in the last trimester of pregnancy or shortly after childbirth. Little is known about psychological or emotional conditions women experience with peripartum card...

Mar 28th, 2020 - Probenecid has been used for decades in the treatment of gout but recently has also been found to improve outcomes in patients with heart failure via stimulation of the transient receptor potential vanilloid 2 (TRPV2) channel in cardiomyocytes. Th...

Aug 2nd, 2010 - Peripartum cardiomyopathy (PPCM) is a cause of pregnancy-associated heart failure. It typically develops during the last month of, and up to 6 months after, pregnancy in women without known cardiovascular disease. The present position statement of...

May 24th, 2020 - The European Society of Cardiology Heart Failure Association Study Group on Peripartum Cardiomyopathy - what has been achieved in 10 years.|2020|Sliwa K,Bauersachs J,Coats AJ,|

May 11th, 2020 - Peripartum cardiomyopathy: can the link between prolactin and PAI-1 provide a clue?|2020|Gorog DA,Vilahur G,|

May 4th, 2020 - Normal cardiac contractile and relaxation function are critically dependent on a continuous energy supply. Accordingly, metabolic perturbations and impaired mitochondrial bioenergetics with subsequent disruption of ATP production underpin a wide v...

Apr 27th, 2020 - Peripartum cardiomyopathy, a traumatic life-threatening type of heart failure, occurs in the last trimester of pregnancy or shortly after childbirth. Little is known about psychological or emotional conditions women experience with peripartum card...

Mar 28th, 2020 - Probenecid has been used for decades in the treatment of gout but recently has also been found to improve outcomes in patients with heart failure via stimulation of the transient receptor potential vanilloid 2 (TRPV2) channel in cardiomyocytes. Th...

Jan 9th, 2020 - For the week ending Jan 10 2020, John Mandrola, MD comments on the following cardiology news [and features] stories: CRF Commissions Review of Controversial EXCEL Trial The Unholy Pairing of Cancer and Peripartum Cardiomyopathy First-time Marathon...

Jan 6th, 2020 - New research bolsters a connection between the risk for cancer before and after peripartum cardiomyopathy (PPCM) and identifies genetic variants underlying PPCM and a variety of cancers. "This study is the first to describe a markedly increased ri...

Nov 7th, 2019 - MONTREAL — A "surprising" and "provocative" study of two cohorts of women who developed peripartum cardiomyopathy (PPCM) in Canada and in the United States suggests that socioeconomic factors — differences in the healthcare systems — rather than g...

Jun 25th, 2019 - Breastfeeding was not associated with worse myocardial recovery in peripartum cardiomyopathy (PPCM), the IPAC study found, throwing into question recommendations against the practice for affected mothers. In the 100-woman observational study, the ...

May 13th, 2019 - The US Food and Drug Administration (FDA)-approved labeling for the Impella 5.0 and Impella LD heart pumps (Abiomed) has been expanded to allow for longer support time in critically ill patients, the company announced today. The devices are approv...